HFL is proud of its international reputation as a leader in cutting-edge analytical science. As a laboratory service provider, HFL is unusual in its level of involvement in scientific research and our scientists regularly publish in peer reviewed journals and present at conferences.

With activities spanning analysis of chemical and biological drugs and their metabolites through to novel biomarkers of drug effect and safety and a range of omics technologies, HFL is involved in a number of leading research projects.

These activities include ongoing internal R&D in novel method establishment, improvement and validation, as well as research funded by Government Agencies and National and International Sports Authorities.

One of the most interesting current examples is HFL's work to develop new sports doping control screening approaches based on measuring the effect of the abuse agent, instead of detecting its presence. This research is particularly important in the light of the increased threat of abuse posed by designer drugs, biological drugs and so-called "gene-doping". HFL is currently being funded by both the World Anti-Doping Agency (WADA) and the Horserace Betting Levy Board (HBLB) in these areas. Together, they form HFL's "New Solutions" project, which HFL is leading in collaboration with a number of expert academic institutes.

 To find out more about our other research activities and ongoing collaborations, or to request a list of our publications, please contact us.